Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab

被引：0
|
作者：
Jessica M. Ruck
Stephen R. Broderick
机构：
[1] Johns Hopkins University School of Medicine,Department of Surgery
来源：
Annals of Surgical Oncology | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 5
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant and Adjuvant Pembrolizumab for the Treatment of Early-Stage Resectable Non-small Cell Lung Cancer An Editorial Regarding the Interim Data Analysis of the KEYNOTE-671 Phase III Trial of Neoadjuvant and Adjuvant Pembrolizumab
    Ruck, Jessica M.
    Broderick, Stephen R.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 4 - 5
  • [2] Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
    Spicer, Jonathan D.
    Garassino, Marina C.
    Wakelee, Heather
    Liberman, Moishe
    Kato, Terufumi
    Tsuboi, Masahiro
    Lee, Se-Hoon
    Chen, Ke-Neng
    Dooms, Christophe
    Majem, Margarita
    Eigendorff, Ekkehard
    Martinengo, Gaston L.
    Bylicki, Olivier
    Rodriguez-Abreu, Delvys
    Chaft, Jamie E.
    Novello, Silvia
    Yang, Jing
    Arunachalam, Ashwini
    Keller, Steven M.
    Samkari, Ayman
    Gao, Shugeng
    LANCET, 2024, 404 (10459): : 1240 - 1252
  • [3] Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States
    Tian, Wentao
    Niu, Lishui
    Wang, Ziqi
    Lu, Ruoyu
    Xiao, Gang
    Deng, Fuxing
    Tanzhu, Guilong
    Zhou, Rongrong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer
    Bar, J.
    Urban, D.
    Redinsky, I.
    Ackerstein, A.
    Daher, S.
    Kamer, I.
    Onn, A.
    Shulimzon, T.
    Peled, M.
    Zeitlin, N.
    Kremer, R.
    Raskin, S.
    Ben-Nun, A.
    Perelman, M.
    Ofek, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S865 - S866
  • [5] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
    Shukla, Nikhil
    Hanna, Nasser
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 51 - 60
  • [6] Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer NSCLC)
    Spicer, J. D.
    Gao, S.
    Liberman, M.
    Kato, T.
    Tsuboi, M.
    Lee, S. H.
    Chen, K. N.
    Dooms, C.
    Majem, M.
    Eigendorff, E.
    Martinengo, G.
    Bylicki, O.
    Garassino, M. C.
    Abreu, D. Rodriguez
    Chaft, J.
    Novello, S.
    Yang, J.
    Keller, S. M.
    Samkari, A.
    Wakelee, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S1297 - S1298
  • [7] Perioperative pembrolizumab plus platinum-based chemotherapy for resectable locally advanced non-small cell lung cancer: The phase III KEYNOTE-671 study
    Tsuboi, M.
    Luft, A.
    Ursol, G.
    Kato, T.
    Levchenko, E.
    Eigendorff, E.
    Berard, H.
    Zurawski, B.
    Demedts, I.
    Garassino, M. C.
    Yang, J.
    Makarious, K.
    Keller, S. M.
    Wakelee, H. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S801 - S802
  • [8] Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer
    Watanabe, Shun-ichi
    Nakagawa, Kazuo
    Suzuki, Kenji
    Takamochi, Kazuya
    Ito, Hiroyuki
    Okami, Jiro
    Aokage, Keiju
    Saji, Hisashi
    Yoshioka, Hiroshige
    Zenke, Yoshitaka
    Aoki, Tadashi
    Tsutani, Yasuhiro
    Okada, Morihito
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) : 1112 - 1118
  • [9] Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer
    Pisters, KMW
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 23 - 28
  • [10] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    HELIYON, 2023, 9 (09)
12345